Sep 26, 2024 / 08:30PM GMT
Operator
Greetings. Welcome to the Aytu Biopharma fiscal 2024 Q4 earnings call. (Operator Instructions) Please note this conference is being recorded.
I will now turn the conference over to your host, Robert Blum with Lytham Partners. You may begin.
Robert Blum - Lytham Partners - Moderator
All right. Thank you very much. Good afternoon, everyone, and thank you for joining us for as the operator indicated Aytu Biopharma's fiscal 2024 full year and fourth quarter operational and financial results conference call for the period ended June 30, 2024. Joining us on today's call is Aytu's Chief Executive Officer, Josh Disbrow; and the company's Chief Financial Officer, Mark Oki.
At the conclusion of today's prepared remarks, we will open the call for a question and answer session. I'd like to remind everyone that today's call is being recorded. A replay of today's call will be available by using the telephone numbers and conference ID provided in the press release issued earlier today or by utilizing the link on the company's website under Events and
Q4 2024 Aytu Biopharma Inc Earnings Call Transcript
Sep 27, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers